Compare CVS Health Corp (CVS) vs TORM plc (TRMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs TORM plc — how do they compare? CVS Health Corp trades at $86.16 (market cap $112.29B), while TORM plc trades at $40 (market cap $4.12B). The key difference: CVS Health Corp is far larger — about 27.3× TORM plc's market cap, and TORM plc pays the higher dividend (11.03%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and TORM plc for 23 Days on average.
| CVS | TRMD | |
|---|---|---|
Market Cap | $112.29B | $4.12B |
Volume | 7,763,676 | 2,863,116 |
Sector | Health | Industrials |
52-Week High | $110.60 | $41.05 |
52-Week Low | $70.08 | $19.39 |
Typical Hold Time | 83 Days | 23 Days |
Enterprise Value | $174.64B | $4.83B |
Dividend Yield | 3.03% | 11.03% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $86.16, down 2.04% for the day, amid a bearish technical signal. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $2.58 exceeding the $1.85 estimate. Revenue grew to $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst consensus is overwhelmingly positive, with 35 of 41 analysts rating the stock a Buy and a consensus price target of $111.20, implying significant upside. Recent news highlights Aetna's 2027 Medicare plan updates and a quarterly dividend declaration.
The outlook for CVS remains favorable based on fundamental strength and analyst optimism, but risks include reimbursement pressure, regulatory scrutiny, and a high debt load. The stock's current valuation metrics, such as a P/E of 23.17 and P/S of 0.27, appear reasonable relative to historical levels, supporting a constructive view for long-term investors despite near-term technical weakness.
TRMD trades at $39.94, up 2.62% today, with a bullish technical signal from moving averages. The stock shows strong profitability with a 35.52% net income margin and a low P/E of 6.59, indicating potential undervaluation. Recent earnings saw a mix of beats and misses, with Q3 2026 results pending. A $2.40 dividend is scheduled for payment in September 2026, and cash flow trends improved to a net positive in 2026.
The outlook is supported by robust fundamentals and a unanimous buy rating from analysts, but risks include volatile spot rates in the tanker market and recent insider selling. Revenue growth to $1.8B in 2026 underscores operational strength, yet dependence on freight rates poses a near-term headwind for sustained gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About TORM plc
TORM plc is one of the world's largest owners and operators of product tankers, specializing in the transportation of refined oil products like gasoline, jet fuel, and diesel. Operating under its integrated 'One TORM' model, the company maintains a modern, wholly-owned fleet of nearly 90 vessels. It is widely recognized by investors for its aggressive variable dividend policy, which returns a significant portion of its cash flow directly to shareholders during periods of high freight rates.
Read more on TRMD →
